Understanding the mechanisms and treatment options in cancer cachexia.
about
Leucine supplementation differentially enhances pancreatic cancer growth in lean and overweight miceRole of Inflammation in Muscle Homeostasis and MyogenesisExercise for cancer cachexia in adults: Executive summary of a Cochrane Collaboration systematic reviewCachexia and pancreatic cancer: are there treatment options?New insights into pancreatic cancer-induced paraneoplastic diabetesMolecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?Understanding cachexia as a cancer metabolism syndromeMechanisms of metabolic dysfunction in cancer-associated cachexiaAddressing Disease-Related Malnutrition in Healthcare: A Latin American PerspectiveRadiologically Determined Sarcopenia Predicts Morbidity and Mortality Following Abdominal Surgery: A Systematic Review and Meta-AnalysisThe Critical Care Obesity Paradox and Implications for Nutrition Support.Rationale and design of the Adapted Physical Activity in advanced Pancreatic Cancer patients (APACaP) GERCOR (Groupe Coopérateur Multidisciplinaire en Oncologie) trial: study protocol for a randomized controlled trialQuality of life assessment in advanced cancer patients treated at home, an inpatient unit, and a day care center.Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling.Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) TumorsMolecular mechanisms of bone metastasis and associated muscle weakness.Skeletal muscle measures and physical function in older adults with cancer: sarcopenia or myopenia?Exercise Recommendations for the Management of Symptoms Clusters Resulting From Cancer and Cancer TreatmentsFunctional body composition and related aspects in research on obesity and cachexia: report on the 12th Stock Conference held on 6 and 7 September 2013 in Hamburg, Germany.Selective androgen receptor modulators (SARMs) negatively regulate triple-negative breast cancer growth and epithelial:mesenchymal stem cell signalingExercise training as treatment in cancer cachexia.Ketogenic diets: from cancer to mitochondrial diseases and beyond.Attacking the supply wagons to starve cancer cells to death.Pancreatic cancer cachexia: a review of mechanisms and therapeutics.Cancer cachexia, mechanism and treatmentChange of body weight and macrophage inhibitory cytokine-1 during chemotherapy in advanced gastric cancer: what is their clinical significance?Arginine depletion by arginine deiminase does not affect whole protein metabolism or muscle fractional protein synthesis rate in mice.Malignant Drosophila tumors interrupt insulin signaling to induce cachexia-like wasting.Induction of IL-6 by Cytotoxic Chemotherapy Is Associated With Loss of Lean Body and Fat Mass in Tumor-free Female Mice.Proteomic analysis of media from lung cancer cells reveals role of 14-3-3 proteins in cachexia.Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle.Systemic organ wasting induced by localized expression of the secreted insulin/IGF antagonist ImpL2.Non Digestible Oligosaccharides Modulate the Gut Microbiota to Control the Development of Leukemia and Associated Cachexia in Mice.Evaluation of effect of body mass index and weight loss on survival of patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapyTALENs-directed knockout of the full-length transcription factor Nrf1α that represses malignant behaviour of human hepatocellular carcinoma (HepG2) cellsThe Geriatric Nutritional Risk Index Predicts Survival in Elderly Esophageal Squamous Cell Carcinoma Patients with Radiotherapy.Diet-induced obesity and insulin resistance spur tumor growth and cancer cachexia in rats bearing the Yoshida sarcoma.Effects of oral meal feeding on whole body protein breakdown and protein synthesis in cachectic pancreatic cancer patients.Nutritional screening is strongly associated with overall survival in patients treated with targeted agents for metastatic renal cell carcinomaWeight Loss and Mortality in Overweight and Obese Cancer Survivors: A Systematic Review
P2860
Q21195809-965F8027-C31E-4EE3-ACB1-8EAA9188B2EAQ26778322-80B8A1C9-F46B-4A9B-84D3-7C1FECC6DB3BQ26781637-DB8470B0-C680-48B3-8FF0-CA38AAE9EA1BQ27026558-BD8AD64A-C08D-4346-8DC8-A35B79DDE90AQ27687766-D582BD9C-A650-4AFE-92B9-E7646C04766CQ28068034-DD61267C-C04E-41F1-AC32-9564C5589FE1Q28069390-A8F7462C-3377-4866-8FB8-9711AB621E86Q28079213-BC176646-7A9E-48CD-9C61-0D6A6767A0C7Q28088553-924B9349-7457-4507-AD1A-A3628D7F2D1CQ29994656-ED756660-B34E-4AB4-9BBA-8AC222CC2E17Q30248985-4026FA17-69DC-40DE-B30A-A4A82A4DA909Q30667879-D2C32E27-6F2A-40D0-BF15-BE47C06514D5Q33610484-6BD62914-DDC0-419F-9461-A3990E9A4732Q33700636-AEDB8E7F-AE09-45D6-822E-09288AD50A81Q33755034-E47B4EBE-293E-4388-A3C9-5C16FBFD8D13Q33758508-4E39E37D-06DF-4EAA-BB9F-98E4311501D4Q33779613-97F25AA6-C6B9-4D9C-9777-4DC0B103719AQ33907387-B9469CD3-391F-46B3-9062-47F1DC4AFDE7Q33934557-4008E0FA-89B2-490F-BD65-B6867DB3A97CQ33966915-256EDD01-D1E0-4181-A490-A851D58D0FA9Q34418882-557ABE4B-152C-479C-A742-CFC9C72E6227Q34509699-CEB5BD90-5A56-4D7A-9BA0-F740A3C10D01Q34516773-025B2086-888A-4D4F-AC81-16F97B8509D7Q34660312-D988DDAC-221C-4D58-A5E7-D0771FCCCD47Q34669440-1F84E661-3E2A-4672-97AE-C552A308CF06Q35106132-A533BFE6-1A7D-4A19-BC12-CE3DABD8D073Q35182189-A1126B82-DA38-4538-B19C-354CFD9295FEQ35332991-753192B2-026C-4BDE-9AF5-60AD97C6F07DQ35433248-840E11C1-3E76-47FE-81E5-937669466C8FQ35545361-DD965CA4-CA03-4DF1-8521-311381F96F37Q35550169-95DA31EE-93DE-45F1-BB64-C1ADCE2AC010Q35623178-CE1D956E-4AA2-4D88-9F2A-C3E4F4FEF946Q35670313-48669FB1-899A-47B2-AECF-0A9770A33591Q35802343-6A8C680D-5D5E-4848-9E4E-0406C21AC689Q35985845-69150525-216B-4753-B74A-7351E7EAFBDFQ36022485-D9D64DD1-5C3E-45B3-902A-92F67FA73960Q36069598-599712DC-2F57-4893-BF7D-A8FA348720D4Q36074166-D470E27F-FD3A-498D-847E-5A244D88482EQ36074171-B8EFD7CD-E734-415E-9377-2E415CFE85C1Q36242901-73FCFFC3-FD23-457F-B563-465B016AC310
P2860
Understanding the mechanisms and treatment options in cancer cachexia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Understanding the mechanisms and treatment options in cancer cachexia.
@en
type
label
Understanding the mechanisms and treatment options in cancer cachexia.
@en
prefLabel
Understanding the mechanisms and treatment options in cancer cachexia.
@en
P1476
Understanding the mechanisms and treatment options in cancer cachexia.
@en
P2093
Jann Arends
Kenneth Fearon
P2888
P356
10.1038/NRCLINONC.2012.209
P407
P577
2012-12-04T00:00:00Z
P5875
P6179
1018304413